Medication - Medika Life

Research concerning the role of psychedelics in mental health treatment and its superb publicity campaign depends on millions of dollars raised by venture capitalists.

Once-Resistant Rural Court Officials Begin to Embrace Medications to Treat Addiction

Medika Life - June 29, 2023

DANDRIDGE, Tenn. — Rachel Solomon and judges hadn’t been on the best of terms. Then Judge O. Duane Slone “dumbfounded” her. Solomon was given...

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life - August 12, 2020

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI Presents Dangers That Hide With Incredible Ease

SUICIDE: IS AI RESPONSIBLE?

The Trauma of Witnessing Charlie Kirk’s Murder and PTSD

Beyond Stereotypes: The Exceptional Abilities That Make Autistic Minds Invaluable

LATEST

TRENDING

The 50 Most Influential Leaders in Pharmacy 2022 Awards

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

FDA Approval of New Drug for Alzheimer’s Offers Hope

The Power of Lifestyle Choices – The Dose of Truth in “Heal Thyself”

Exponential Innovation: Disrupting The Disruptor

Do Medications Have Psychiatric Side Effects?

How Dare You Criticize Psychiatrists Who Praise Studies of Psychedelics As Antidepressants?

Psilocybin as an Antidepressant for Cancer Patients Who Are Not Depressed

Weight Management During Fertility Treatment: A Challenge But Not a Lost Cause

Does Botox Drop Anxiety?

EDITORS CHOICE

The 50 Most Influential Leaders in Pharmacy 2022 Awards

Psilocybin as an Antidepressant for Cancer Patients Who Are Not Depressed

Once-Resistant Rural Court Officials Begin to Embrace Medications to Treat Addiction

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories